AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
Researched Benefits:
- Facilitates analysis of hGH-derived lipolytic signaling without IGF-1 induction
- Supports investigation into phosphorylation-mediated lipid metabolism and fat oxidation
- Enables comparative modeling of non-diabetogenic growth hormone fragment activity
- Useful for probing metabolic pathways governing adipose tissue remodeling assays
Description
AOD-9604 is a research-grade peptide used extensively in obesity research and muscle regeneration studies. Sourced from high-quality raw materials and synthesized using state-of-the-art technology, our AOD-9604 is guaranteed for its purity and efficacy in research applications.
Key Features:
- Synthesized to the highest industry standards
- Rigorous quality control and batch consistency
- Lyophilized for long-term stability
Applications:
- Promotes fat loss and inhibits lipogenesis
- Enhances muscle regeneration and repair
- Investigates metabolic disorders and obesity-related diseases
AOD-9604 is a modified form of fragment of the human growth hormone (GH) which encompasses the fat reducing activity of GH without its muscle-building effects, making it extremely sought after for research aimed at understanding fat metabolism and developing anti-obesity treatments.
